Tema Oncology ETF
CANC
3 hedge funds and large institutions have $240K invested in Tema Oncology ETF in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.16% less ownership
Funds ownership: 1.43% → 1.27% (-0.16%)
4% less capital invested
Capital invested by funds: $250K → $240K (-$9.81K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$26.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $225K | -$26.6K | -978 | -11% |
|
|
HI
2
Harbour Investments
Madison,
Wisconsin
| $8.88K | – | – | – |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $5.62K | +$1.36K | +50 | +33% |
|
CANC Hedge Fund Activity: Q1 2024 in Review
3 of the 6,948 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q1 2024, worth a combined $240K — down 3.9% from $250K a quarter earlier.
Fund positioning in CANC was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Osaic Holdings, adding an estimated $1.36K. The largest seller was Jane Street, cutting an estimated $26.6K.
- 3 institutional investors held Tema Oncology ETF (CANC) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $240K of Tema Oncology ETF stock for Q1 2024, down 3.9% quarter-over-quarter.
- 0 funds opened new Tema Oncology ETF positions in Q1 2024 and 0 closed out.
- The largest Tema Oncology ETF buyer in Q1 2024 was Osaic Holdings, an estimated $1.36K added.
- The largest Tema Oncology ETF seller in Q1 2024 was Jane Street, an estimated $26.6K sold.
Based on aggregated 13F filings for Q1 2024.